Olga Kantor1, Darren S Bryan1, Mark S Talamonti2,3, Waseem Lutfi1, Susan Sharpe4, David J Winchester2,3, Richard A Prinz2,3, Marshall S Baker5,6. 1. Department of Surgery, University of Chicago, Chicago, IL, USA. 2. Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA. 3. Pritzker School of Medicine, University of Chicago, Chicago, IL, USA. 4. Department of Surgery, MetroHealth Medical Center, Cleveland, OH, USA. 5. Department of Surgery, NorthShore University HealthSystem, Evanston, IL, USA. Mbaker3@northshore.org. 6. Pritzker School of Medicine, University of Chicago, Chicago, IL, USA. Mbaker3@northshore.org.
Abstract
BACKGROUND: Laparoscopic distal pancreatectomy (LDP) has been shown to provide short-term clinical outcomes similar to open distal pancreatectomy (ODP) for patients with benign tumors. Our aim was to better define oncologic outcomes and long-term survival profiles following LDP for pancreatic ductal adenocarcinoma (PDAC). METHODS: We queried the National Cancer Database to identify patients with pathologic stage I-III PDAC who underwent distal pancreatectomy between 2010 and 2013. Logistic regression was performed to examine predictors of oncologic outcomes. Cox modeling was used for survival analysis and to estimate median overall survival (OS). RESULTS: One thousand five hundred fifty-four patients were included in the analysis. Patients undergoing LDP and ODP demonstrated identical probabilities of an adequate lymph node sampling and 90-day mortality. Those undergoing LDP demonstrated an increased probability of margin-negative resection (OR 1.78, CI 1.25-2.52) and a decreased probability of a prolonged hospital stay (OR 0.55, CI 0.32-0.95) or readmission (OR 0.56, CI 0.33-0.95) relative to those undergoing ODP. There was no difference in OS between groups (29.6 vs. 23.8 months, p = 0.10). CONCLUSION: LDP is an effective modality for managing resectable cancer in the pancreatic body and tail. LDP provides short-term oncologic outcomes and long-term OS rates identical to those for ODP while affording an accelerated recovery.
BACKGROUND: Laparoscopic distal pancreatectomy (LDP) has been shown to provide short-term clinical outcomes similar to open distal pancreatectomy (ODP) for patients with benign tumors. Our aim was to better define oncologic outcomes and long-term survival profiles following LDP for pancreatic ductal adenocarcinoma (PDAC). METHODS: We queried the National Cancer Database to identify patients with pathologic stage I-III PDAC who underwent distal pancreatectomy between 2010 and 2013. Logistic regression was performed to examine predictors of oncologic outcomes. Cox modeling was used for survival analysis and to estimate median overall survival (OS). RESULTS: One thousand five hundred fifty-four patients were included in the analysis. Patients undergoing LDP and ODP demonstrated identical probabilities of an adequate lymph node sampling and 90-day mortality. Those undergoing LDP demonstrated an increased probability of margin-negative resection (OR 1.78, CI 1.25-2.52) and a decreased probability of a prolonged hospital stay (OR 0.55, CI 0.32-0.95) or readmission (OR 0.56, CI 0.33-0.95) relative to those undergoing ODP. There was no difference in OS between groups (29.6 vs. 23.8 months, p = 0.10). CONCLUSION: LDP is an effective modality for managing resectable cancer in the pancreatic body and tail. LDP provides short-term oncologic outcomes and long-term OS rates identical to those for ODP while affording an accelerated recovery.
Authors: Raghunandan Venkat; Barish H Edil; Richard D Schulick; Anne O Lidor; Martin A Makary; Christopher L Wolfgang Journal: Ann Surg Date: 2012-06 Impact factor: 12.969
Authors: S Rehman; S K P John; R Lochan; B C Jaques; D M Manas; R M Charnley; J J French; S A White Journal: World J Surg Date: 2014-02 Impact factor: 3.352
Authors: Hop S Tran Cao; Nicole Lopez; David C Chang; Andrew M Lowy; Michael Bouvet; Joel M Baumgartner; Mark A Talamini; Jason K Sicklick Journal: JAMA Surg Date: 2014-03 Impact factor: 14.766
Authors: David A Kooby; William G Hawkins; C Max Schmidt; Sharon M Weber; David J Bentrem; Theresa W Gillespie; Johnita Byrd Sellers; Nipun B Merchant; Charles R Scoggins; Robert C G Martin; Hong Jin Kim; Syed Ahmad; Clifford S Cho; Alexander A Parikh; Carrie K Chu; Nicholas A Hamilton; Courtney J Doyle; Scott Pinchot; Amanda Hayman; Rebecca McClaine; Attila Nakeeb; Charles A Staley; Kelly M McMasters; Keith D Lillemoe Journal: J Am Coll Surg Date: 2010-05 Impact factor: 6.113
Authors: Marshall S Baker; Karen L Sherman; Susan Stocker; Amanda V Hayman; David J Bentrem; Richard A Prinz; Mark S Talamonti Journal: J Gastrointest Surg Date: 2012-12-06 Impact factor: 3.452
Authors: Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; David P Winchester; Clifford Y Ko Journal: J Clin Oncol Date: 2009-07-27 Impact factor: 44.544
Authors: Ryan P Merkow; Karl Y Bilimoria; James S Tomlinson; Jennifer L Paruch; Jason B Fleming; Mark S Talamonti; Clifford Y Ko; David J Bentrem Journal: Ann Surg Date: 2014-08 Impact factor: 12.969
Authors: M Korrel; S Lof; J van Hilst; A Alseidi; U Boggi; O R Busch; S van Dieren; B Edwin; D Fuks; T Hackert; T Keck; I Khatkov; G Malleo; I Poves; M A Sahakyan; C Bassi; M Abu Hilal; M G Besselink Journal: Ann Surg Oncol Date: 2020-06-25 Impact factor: 5.344
Authors: Yeon Su Kim; Ji Su Kim; Sung Hyun Kim; Ho Kyoung Hwang; Woo Jung Lee; Chang Moo Kang Journal: Ann Hepatobiliary Pancreat Surg Date: 2022-02-28